Comments on Condition of the Public Health Industrial Base and Recommendations

Share page:

Comments | Dec 23, 2020

Docket Number:
BIS-2020-0034

Supply chain resilience is essential to ensure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises. While there is a strong U.S. manufacturing capacity for consumer healthcare products in finished dosage form, supply chain resilience relies on a diverse, global supply chain to reduce the risk of shortages or disruptions that may occur in a particular geographical area. Such disruptions not only include pandemics or geopolitical issues, but issues within the U.S., such as a natural disaster. Having ingredient suppliers in different parts of the world allows manufacturers an alternate source for procurement when an interruption occurs to reduce the impact of such disruptions.